Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
BAYER HEALTHCARE LLC - 27 Mar 2026 SCHEDULE 13D/A Report for Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI)
- Filing manager
- BAYER HEALTHCARE LLC
- Reporting owner
- Bayer HealthCare LLC
- Beneficially owned shares
- 6,142,848 shares
- Large-stake signal
-
Ownership
18%Beneficial ownership of this reported class.
Shares
6,142,848 sharesShares beneficially owned as disclosed.
Event date
27 Mar 2026Date tied to the ownership event or amendment.
Accepted by SEC
16 Apr 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 18%
- Symbol
- SNTI
- Shares outstanding
- 34,471,650 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 16 Apr 2026, 16:50:40 UTC
- Event date
- 27 Mar 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
BAYER HEALTHCARE LLC disclosed 18% ownership in Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI) on 27 Mar 2026.
Key facts
- BAYER HEALTHCARE LLC filed SCHEDULE 13D/A for Senti Biosciences, Inc. Common Stock, par value $0.0001 per share (SNTI).
- Disclosed ownership: 18%.
- Date of event: 27 Mar 2026.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 16 Apr 2026, 16:50.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (4)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bayer HealthCare LLC | 18% | 6,142,848 | 0 | 6,142,848 | /s/ Priyal Patel | Priyal Patel, President | 0001231517 |
| Bayer US Holding LLC | 18% | 6,142,848 | 0 | 6,142,848 | /s/ Sebastian Guth | Sebastian Guth, President | 0001965754 |
| Sebastian Guth | 18% | 6,142,848 | 0 | 6,142,848 | /s/ Sebastian Guth | Sebastian Guth | |
| Priyal Patel | 18% | 6,142,848 | 0 | 6,142,848 | /s/ Priyal Patel | Priyal Patel |
CIK / CUSIP context first